hydralazine has been researched along with Obstructive Lung Diseases in 16 studies
Hydralazine: A direct-acting vasodilator that is used as an antihypertensive agent.
hydralazine : The 1-hydrazino derivative of phthalazine; a direct-acting vasodilator that is used as an antihypertensive agent.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Reports on hemodynamic effects of hydralazine on pulmonary hypertension (primary or secondary) usually include cases with severe disease or with mixed varieties of pulmonary vascular disease." | 7.67 | Effects of hydralazine on hemodynamics, ventilation, and gas exchange in patients with chronic obstructive pulmonary disease and pulmonary hypertension. ( Chun, DS; Dolan, GF; Keller, CA; Minh, VD; Shepard, JW; Vasquez, P, 1984) |
| "Hydralazine was administered to eight patients (mean age, 69 +/- 2 years) who had stable, advanced chronic obstructive pulmonary disease (COPD), pulmonary arterial hypertension (mean pulmonary arterial pressure, 31 +/- 3 mm Hg), and cor pulmonale." | 7.67 | Hemodynamic effect of hydralazine in advanced, stable chronic obstructive pulmonary disease with cor pulmonale. Immediate and short-term evaluation at rest and during exercise. ( Lupi-Herrera, E; Seoane, M; Verdejo, J, 1984) |
| "Hydralazine has been shown to increase minute ventilation, alveolar ventilation, and arterial partial pressure of oxygen (PaO2) after short-term administration in patients with chronic obstructive pulmonary disease and pulmonary hypertension." | 7.67 | Long-term effects of hydralazine on ventilation and blood gas values in patients with chronic obstructive pulmonary disease and pulmonary hypertension. ( Corriveau, ML; Dolan, GF, 1987) |
| "Hydralazine has been shown to increase minute ventilation (VE) in patients with chronic obstructive pulmonary disease and pulmonary hypertension." | 7.67 | Effects of hydralazine on mouth occlusion pressure and ventilatory response to hypercapnia in patients with chronic obstructive pulmonary disease and pulmonary hypertension. ( Corriveau, ML; Dolan, GF; Shepard, JW, 1987) |
| "Reports on hemodynamic effects of hydralazine on pulmonary hypertension (primary or secondary) usually include cases with severe disease or with mixed varieties of pulmonary vascular disease." | 3.67 | Effects of hydralazine on hemodynamics, ventilation, and gas exchange in patients with chronic obstructive pulmonary disease and pulmonary hypertension. ( Chun, DS; Dolan, GF; Keller, CA; Minh, VD; Shepard, JW; Vasquez, P, 1984) |
| "Hydralazine was administered to eight patients (mean age, 69 +/- 2 years) who had stable, advanced chronic obstructive pulmonary disease (COPD), pulmonary arterial hypertension (mean pulmonary arterial pressure, 31 +/- 3 mm Hg), and cor pulmonale." | 3.67 | Hemodynamic effect of hydralazine in advanced, stable chronic obstructive pulmonary disease with cor pulmonale. Immediate and short-term evaluation at rest and during exercise. ( Lupi-Herrera, E; Seoane, M; Verdejo, J, 1984) |
| "Hydralazine has been shown to increase minute ventilation, alveolar ventilation, and arterial partial pressure of oxygen (PaO2) after short-term administration in patients with chronic obstructive pulmonary disease and pulmonary hypertension." | 3.67 | Long-term effects of hydralazine on ventilation and blood gas values in patients with chronic obstructive pulmonary disease and pulmonary hypertension. ( Corriveau, ML; Dolan, GF, 1987) |
| " Because Indo may interfere with the hypotensive effect of hydralazine and because hydralazine has been proposed in the treatment of patients with pulmonary hypertension, 7 of these patients also received 0." | 3.67 | Effects of indomethacin on pulmonary hemodynamics and gas exchange in patients with pulmonary artery hypertension, interference with hydralazine. ( Adnot, S; Brun-Buisson, C; de Cremoux, H; Defouilloy, C; Lemaire, F; Piquet, J, 1987) |
| "Hydralazine has been shown to increase minute ventilation (VE) in patients with chronic obstructive pulmonary disease and pulmonary hypertension." | 3.67 | Effects of hydralazine on mouth occlusion pressure and ventilatory response to hypercapnia in patients with chronic obstructive pulmonary disease and pulmonary hypertension. ( Corriveau, ML; Dolan, GF; Shepard, JW, 1987) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 14 (87.50) | 18.7374 |
| 1990's | 2 (12.50) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tuxen, DV | 1 |
| Powles, AC | 1 |
| Mathur, PN | 1 |
| Pugsley, SO | 1 |
| Campbell, EJ | 1 |
| Brent, BN | 2 |
| Berger, HJ | 2 |
| Matthay, RA | 2 |
| Mahler, D | 1 |
| Pytlik, L | 1 |
| Zaret, BL | 2 |
| Keller, CA | 2 |
| Shepard, JW | 2 |
| Chun, DS | 2 |
| Dolan, GF | 4 |
| Vasquez, P | 1 |
| Minh, VD | 1 |
| Cordasco, EM | 1 |
| Rüegger, M | 1 |
| Medici, TC | 1 |
| Lupi-Herrera, E | 1 |
| Seoane, M | 1 |
| Verdejo, J | 1 |
| Mahler, DA | 1 |
| Lister, G | 1 |
| Jankowska, R | 1 |
| Passowicz-Muszyńska, E | 1 |
| Banaś, T | 1 |
| Marcinkowska, A | 1 |
| Medrala, W | 1 |
| Lewczuk, J | 1 |
| Wrabec, K | 1 |
| Corriveau, ML | 3 |
| Rosen, BJ | 1 |
| Adnot, S | 1 |
| Defouilloy, C | 1 |
| Brun-Buisson, C | 1 |
| Piquet, J | 1 |
| de Cremoux, H | 1 |
| Lemaire, F | 1 |
| Dal Nogare, AR | 1 |
| Rubin, LJ | 1 |
| Cerdá, E | 1 |
| Esteban, A | 1 |
| de la Cal, MA | 1 |
| Fernández, A | 1 |
| García, A | 1 |
1 review available for hydralazine and Obstructive Lung Diseases
| Article | Year |
|---|---|
[Value of vasodilator agents in the treatment of diseases with pulmonary hypertension caused by chronic obstructive lung diseases].
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Calcium Channel B | 1991 |
15 other studies available for hydralazine and Obstructive Lung Diseases
| Article | Year |
|---|---|
Detrimental effects of hydralazine in patients with chronic air-flow obstruction and pulmonary hypertension. A combined hemodynamic and radionuclide study.
Topics: Aged; Angiography; Female; Hemodynamics; Humans; Hydralazine; Hypertension, Pulmonary; Lung Diseases | 1984 |
Contrasting acute effects of vasodilators (nitroglycerin, nitroprusside, and hydralazine) on right ventricular performance in patients with chronic obstructive pulmonary disease and pulmonary hypertension: a combined radionuclide-hemodynamic study.
Topics: Adult; Aged; Female; Heart; Hemodynamics; Humans; Hydralazine; Hypertension, Pulmonary; Lung Disease | 1983 |
Effects of hydralazine on hemodynamics, ventilation, and gas exchange in patients with chronic obstructive pulmonary disease and pulmonary hypertension.
Topics: Drug Tolerance; Hemodynamics; Humans; Hydralazine; Hypertension, Pulmonary; Lung Diseases, Obstructi | 1984 |
Pulmonary vascular disease--overview.
Topics: Angiography; Heparin; Humans; Hydralazine; Hypertension, Pulmonary; Lung; Lung Diseases, Obstructive | 1983 |
[New therapies for cor pulmonale?].
Topics: Bloodletting; Humans; Hydralazine; Hypertension, Pulmonary; Hypoxia; Iron; Lung Diseases, Obstructiv | 1983 |
Hemodynamic effect of hydralazine in advanced, stable chronic obstructive pulmonary disease with cor pulmonale. Immediate and short-term evaluation at rest and during exercise.
Topics: Aged; Bronchitis; Hemodynamics; Humans; Hydralazine; Lung Diseases, Obstructive; Male; Middle Aged; | 1984 |
Relationship between oxygen uptake and oxygen transport in stable patients with chronic obstructive pulmonary disease. Physiologic effects of nitroprusside and hydralazine.
Topics: Aged; Biological Transport; Ferricyanides; Hemodynamics; Humans; Hydralazine; Hypertension, Pulmonar | 1984 |
Hydralazine in pulmonary hypertension.
Topics: Humans; Hydralazine; Hypertension, Pulmonary; Lung Diseases, Obstructive; Nifedipine | 1982 |
[The influence of vitamin A on production of oxygen free radicals and activity of granulocyte catalase in patients with chronic bronchitis].
Topics: Acetylcysteine; Adult; Aged; Catalase; Cells, Cultured; Female; Free Radicals; Granulocytes; Humans; | 1994 |
Effect of posture, hydralazine, and nifedipine on hemodynamics, ventilation, and gas exchange in patients with chronic obstructive pulmonary disease.
Topics: Carbon Dioxide; Carbon Monoxide; Hemodynamics; Humans; Hydralazine; Hypertension, Pulmonary; Lung Di | 1988 |
Long-term effects of hydralazine on ventilation and blood gas values in patients with chronic obstructive pulmonary disease and pulmonary hypertension.
Topics: Blood Gas Analysis; Follow-Up Studies; Humans; Hydralazine; Hypertension, Pulmonary; Lung Diseases, | 1987 |
Effects of indomethacin on pulmonary hemodynamics and gas exchange in patients with pulmonary artery hypertension, interference with hydralazine.
Topics: Aged; Cardiac Catheterization; Drug Evaluation; Drug Interactions; Female; Hemodynamics; Humans; Hyd | 1987 |
Effects of hydralazine on mouth occlusion pressure and ventilatory response to hypercapnia in patients with chronic obstructive pulmonary disease and pulmonary hypertension.
Topics: Administration, Oral; Cardiac Catheterization; Drug Evaluation; Hemodynamics; Humans; Hydralazine; H | 1987 |
The effects of hydralazine on exercise capacity in pulmonary hypertension secondary to chronic obstructive pulmonary disease.
Topics: Exercise Test; Hemodynamics; Humans; Hydralazine; Hypertension, Pulmonary; Lung Diseases, Obstructiv | 1986 |
Hemodynamic effects of vasodilators on pulmonary hypertension in decompensated chronic obstructive pulmonary disease.
Topics: Aged; Blood Pressure; Female; Ferricyanides; Heart Rate; Hemodynamics; Humans; Hydralazine; Hyperten | 1985 |